logo
episode-header-image
Sep 2025
22m 31s

Wary pharma: AstraZeneca sours on UK

The Economist
About this episode
tail spinning
Up next
May 1
Beirut watch: can Lebanon subdue Hizbullah?
Can peace hold in Lebanon while Hizbullah remains? Our correspondent weighs the balance of power between government forces and the Iran-backed militia. The resale value of Labubus is falling – who cares? And remembering Swedish death-clearer, Margareta Magnusson. Watch extended c ... Show More
23m 20s
Apr 30
Drill pickle: oil prices still misjudge shock
Oil prices are at their highest since 2022, as a swift end to the Iran conflict proves elusive. Yet, our commodities editor says, markets do not yet yet recognise how deep the supply shock is. Who will contest next year’s pivotal election in France? And great expectations in Braz ... Show More
19m 53s
Apr 29
Power ranges: AI faces supply crunch
Artificial Intelligence is becoming ubiquitous, but the industry that powers it is struggling to keep up with demand. The host of our award-winning podcast series “Scam Inc” says fraudsters in Asia are becoming more sophisticated. And after Allbirds stops selling shoes, what come ... Show More
22m 44s
Recommended Episodes
Sep 2025
Wary pharma: AstraZeneca sours on UK
Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ... Show More
22m 31s
Nov 2024
Rio brand: why Brazil is courting China
<p>Trade ties between <a href="https://www.economist.com/the-americas/2024/11/17/brazil-courts-china-as-its-musk-feud-erupts-again?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&utm_term= ... Show More
20m 45s
Sep 2025
Call the shots: vaccine cuts imperil global health
America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newes ... Show More
21m 26s
Aug 2025
Trouble in paradise: US plans for Pacific war
With China as its new rival, America is reviving old wartime facilities across the Pacific. Our correspondent visits an abandoned airfield that has been given new life. The outlook for climate technology is surprisingly bright. And why the universe of Hello Kitty keeps expanding. ... Show More
22m 34s
Apr 2024
Money Talks: Why weight-loss drugs will reshape the world
<p>More than 1bn people around the world are obese. That means there should be extraordinary demand for drugs to cure or mitigate the condition. Novo Nordisk is now Europe’s most valuable company and Eli Lilly’s market value has more than doubled. Both make the “miracle” drugs th ... Show More
36m 59s
Jan 2025
Putty people: can Trump get his picks?
<p>As some of Donald Trump’s most <a href="https://www.economist.com/united-states/2025/01/29/kash-patel-is-a-crackpot?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&utm_term=sa.listeners ... Show More
23m 20s
Oct 2025
Cocaine and able: drug runners innovate
America has been blowing up ships in foreign waters suspected of carrying drugs. That will do little to dent today’s narco-business, which is more inventive and adaptable than ever. Why business executives in China keep disappearing. And the jewels stolen in the brazen Louvre hei ... Show More
24m 16s
Oct 2025
Wrong side of the hack: cybercrime grows
Cyberattacks have brought firms like Jaguar Land Rover and Asahi to a standstill. Our correspondent asks what companies and governments should do about a rising problem. Why it is getting harder to count deaths in Africa. And is eating dark chocolate actually good for you? Listen ... Show More
21m 45s
Aug 2025
Stake and chips: will America take 10% of Intel?
Intel was once synonymous with chip-making, but in recent years it has fallen behind. Now the Trump administration may become its biggest shareholder. A political assassination in Colombia raises fears about a return to violence. And what an annual snail race tells us about rural ... Show More
21m 2s
Oct 2025
Aid pro quo: Trump weaponises foreign help
After cancelling much of America’s international development funding, President Donald Trump is now using that money to boost friends, allies against China and buy goods and influence. Ukraine is striking Russia’s fuel infrastructure deep inside the country. And why JD Wetherspoo ... Show More
23m 32s